Stocklytics Platform
Asset logo for symbol TECH
Bio-Techne
TECH48
$46.86arrow_drop_down1.22%-$0.57
S&P500
Asset logo for symbol TECH
TECH48

$46.86

arrow_drop_down1.22%

Performance History

Chart placeholder
Key Stats
Open$46.24
Prev. Close$47.32
EPS0.98
Next Earnings Date-
LOWHIGH
Day Range45.65
47.31
52 Week Range45.43
85.57
Ratios
EPS0.98

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Bio-Techne (TECH)

Bio-Techne Corp (TECH) is a leading provider of innovative life science tools and services. The company operates in two segments: Protein Sciences and Diagnostics. It offers a wide range of products, including antibodies, proteins, immunoassays, and RNA-sequencing kits, which are used by researchers and scientists worldwide. Bio-Techne's products are used in various applications, such as drug discovery, diagnostics, and personalized medicine. The company has a strong track record of innovation and has been awarded numerous patents for its technologies.
Bio-Techne Corp has a market cap of $15.4 billion and a PEG ratio of 2.86. Its stock price has shown strong performance over the past year, with a 52-week range of $160.52 to $317.82. The stock is currently trading at $295.68, near its all-time high. The company has a high trading volume, indicating strong investor interest. Bio-Techne Corp's financial performance has been impressive, with strong revenue growth and profitability. Its revenue for the last fiscal year was $893 million, with a net income of $210 million.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Charles R. Kummeth
Headquarters
Minneapolis
Employees
3000
Exchange
NASDAQ
add Bio-Techne to watchlist

Keep an eye on Bio-Techne

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Bio-Techne's (TECH) price per share?

The current price per share for Bio-Techne (TECH) is $46.86. The stock has seen a price change of -$0.58 recently, indicating a -1.23% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Bio-Techne (TECH)?

For Bio-Techne (TECH), the 52-week high is $85.57, which is 82.61% from the current price. The 52-week low is $45.44, the current price is 3.14% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Bio-Techne (TECH) a growth stock?

Bio-Techne (TECH) has shown an average price growth of -1.65% over the past three years. It has received a score of 26 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Bio-Techne as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Bio-Techne (TECH) stock price performance year to date (YTD)?

As of the latest data, Bio-Techne (TECH) has a year-to-date price change of -34.94%. Over the past month, the stock has experienced a price change of -4.52%. Over the last three months, the change has been -28.52%. Over the past six months, the figure is -34.26%. Looking at a longer horizon, the five-year price change stands at -29.64%.
help

Is Bio-Techne (TECH) a profitable company?

Bio-Techne (TECH) has a net income of $168.07M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 66.41% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 17.76% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.16B, with a revenue growth rate of 1.97%, providing insight into the company's sales performance and growth. The gross profit is $769.72M. Operating income is noted at $206.69M. Furthermore, the EBITDA is $345.78M.
help

What is the market capitalization of Bio-Techne (TECH)?

Bio-Techne (TECH) has a market capitalization of $7.56B. The average daily trading volume is 46.64, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level